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Background: It is not clear whether ginseng affects cyclosporine A (CsA)-induced desirable immuno-
suppressive action. In this study, we evaluated the immunological inﬂuence of combined treatment of
ginseng with CsA.
Methods: Using CD4þ T cells from mouse spleens stimulated with the T cell receptor (TCR) or allogeneic
antigen-presenting cells (APCs), we examined the differentiation of naïve T cells into T helper 1 (Th1),
Th2, Th17, and regulatory T cells (Tregs), and their cytokine production during treatment by Korean Red
Ginseng extract (KRGE) and/or CsA. The inﬂuence of KRGE on the allogeneic T cell response was eval-
uated by mixed lymphocyte reaction (MLR). We also evaluated whether signal transducer and activator
of transcription 3 (STAT3) and STAT5 are implicated in this regulation.
Results: Under TCR stimulation, KRGE treatment did not affect the population of CD4þinterferon gamma
(IFNg)þ and CD4þinterleukin (IL)-4þ cells and their cytokine production compared with CsA alone.
Under the Th17-polarizing condition, KRGE signiﬁcantly reduced the number of CD4þIL-17þ cells and
CD4þ/phosphorylated STAT3 (p-STAT3)þ cells, but increased the number of CD4þCD25þforkhead box
P3 (Foxp3)þ cells and CD4þ/p-STAT5þ cells compared with CsA alone. In allogeneic APCs-stimulated
CD4þ T cells, KRGE signiﬁcantly decreased total allogeneic T cell proliferation. Consistent with the ef-
fects of TCR stimulation, KRGE reduced the number of CD4þIL-17þ cells and increased the number of
CD4þCD25þFoxp3þ cells under the Th17-polarizing condition.
Conclusion: KRGE has immunological beneﬁts through the reciprocal regulation of Th17 and Treg cells
during CsA-induced immunosuppression.
Copyright  2015, The Korean Society of Ginseng, Published by Elsevier Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Calcineurin inhibitors (CNIs) such as cyclosporine A (CsA) and
tacrolimus are widely used immunosuppressants in solid organ
transplantation. CNIs efﬁciently inhibit interleukin (IL)-2 tran-
scription and therefore ultimately prevent T cell activation [1,2]. In
addition, CNIs reduce the frequency and function of CD4þ regula-
tory T cells (Tregs) and upregulates T helper type 17 (Th17) cell-partment of Internal Medicine, Se
.
ht  2015, The Korean Society of G
c-nd/4.0/).associated pathways [3e6]. It is well known that Th17 secretes
proinﬂammatory cytokine IL-17 [7,8] and is regulated by signal
transducer and activator of transcription (STAT) 3. By contrast, the
Treg population is associated with immune tolerance and is regu-
lated by STAT5, which binds to the forkhead box P3 (Foxp3) pro-
moter [9e11]. A recent paper suggested a competition model in
which relative activation of STAT3 and STAT5 directly dictates the
outcome of IL-17 production in CD4þ T cells [12].oul St. Mary’s Hospital, The Catholic University of Korea 641 Banpo-ro, Seocho-gu,
inseng, Published by Elsevier Ltd. This is an open access article under the CC BY-NC-
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for preventing autoimmune and allogeneic immune disorders [13e
15]. Interestingly, Jhun et al. [16] suggested that Korean Red
Ginseng (KRG) could ameliorate arthritis in mice with collagen-
induced arthritis, through suppression of Th17 differentiation by
inhibiting phosphorylation of STAT3 and reciprocally increasing
Treg population. Based on these observations of STAT3 inhibition by
ginseng, it is expected that combined treatment of KRG would
suppress the differentiation of pathogenic Th17 cells through the
inhibition of STAT3 during CsA treatment.
Therefore, we designed this study to evaluate the inﬂuence of
KRG on CsA-induced immunosuppression using isolated CD4þ
splenocytes. First, we veriﬁed the frequency and expression of the
Th17 and Treg cells as well as Th1 and Th2 during stimulation with
the T cell receptor (TCR). Second, we further examined those
affected by stimulation of alloantigen, which is mimicking rejection
conditions. We also tested the expression of phosphorylation of
STAT3 and STAT5 as the regulation mechanism of Th17 and Treg.
2. Materials and methods
2.1. Mice and drugs
C57BL/6 (H-2Kb) and BALB/c (H-2Kd) mice, 8e10-wk-old, were
purchased from OrientBio (Sungnam, Korea). The mice were
maintained under speciﬁc pathogen-free conditions in an animal
facility with controlled humidity (55  5%), light (12 h/12 h light/
dark), and temperature (22  1C). The air in the clean bench was
passed through a high efﬁciency particulate air ﬁlter system
designed to eliminate bacteria and viruses. Mice were fed animal
chow and tap water ad libitum. The animal protocol was approved
by the Animal Care and Use Committee of the Catholic University of
Korea. CsA (Sigma-Aldrich, St. Louis, MO, USA) was diluted in sterile
phosphate-buffered saline. KRG extract (KRGE) was obtained from
Korea Ginseng Corporation (Seoul, Korea) and was diluted in sterile
phosphate-buffered saline. According to the manufacturer’s data,
the main components of the KRGE were Rg1 (2.01%), Rb1 (8.27%),
Rg3 (1.04%), Re (2.58%), Rc (3.90%), Rb2 (3.22%), Rd (1.09%), Rf
(1.61%), Rh1 (0.95%), and Rg2 (s) (1.35%).
2.2. Cytotoxicity assay
Cell viability was assessed using propidium iodide (PI) staining
solution (BD Biosciences, San Jose, CA, USA). Isolated CD4þ T cells
were cultured with various concentrations of CsA (3 ng/mL, 10 ng/
mL, 30 ng/mL, 60 ng/mL) or KRGE (3 mg/mL,10 mg/mL, 30 mg/mL) for
72 h. Viable and dead cells were distinguished using ﬂow cyto-
metric analysis on a ﬂuorescence-activated cell sorting LSRII For-
tessa (BD Biosciences).
2.3. CD4þ T cell isolation and differentiation
Spleens were removed from C57BL/6 mice and minced. Splenic
red blood cells were removedwith ammonium-chloride-potassium
lysis buffer (0.15M NH4Cl, 1mM KHCO3, 0.1mM Na2 EDTA,
pH 7.2w7.4). The cells were resuspended in complete media con-
taining RPMI 1640 supplemented with 5% fetal bovine serum and
1% antibiotics (all from Gibco, Grand Island, NY, USA). CD4þ T cells
were isolated using a CD4þ T cell isolation kit (Miltenyi Biotec, San
Diego, CA, USA), according to the manufacturer’s protocol. The
purity of isolated CD4þ T cells was assessed as > 95%. Negatively
selected non-CD4þ cells were regarded as antigen-presenting cells
(APCs) and irradiated at 3,000 rad before coculture. Isolated CD4þ T
cells were stimulated with plate-bound anti-CD3 (0.5 mg/mL) and
soluble anti-CD28 (1 mg/mL) (both from BD Biosciences) in thepresence or absence of CsA (30 ng/mL) and KRGE (3 mg/mL or 10 mg/
mL) for 72 h. For Th17 cell-polarizing condition, isolated CD4þ T
cells were stimulatedwith plate-bound anti-CD3mAb (0.5 mg/mL),
soluble anti-CD28 mAb (1 mg/mL), anti-interferon (IFN) g (2 mg/
mL), anti-IL-4 (2 mg/mL), anti-IL-2 (2 mg/mL), IL-6 (20 ng/mL) (all
from R&D Systems, Minneapolis, MN, USA), and transforming
growth factor-beta (2 ng/mL, PeproTech, London, UK) for 72 h
[16,17].
2.4. Flow cytometry
Expression of cytokines and transcription factors was assessed
by intracellular staining. The following antibodies were used for
intracellular staining of mouse cells: anti-CD4- peridinin chloro-
phyll or -ﬂuorescein isothiocyanate, anti-CD25-eFluor 450, anti-IL-
17-phycoerythrin (PE), anti-Foxp3-allophycocyanin (APC), anti-
IFNg-peridinin chlorophyll-cyanine 5.5, and anti-IL-4-PE-cyanine 7
(all from eBioscience, San Diego, CA, USA). Cells were stimulated for
4 h with phorbol 12-myristate 13-acetate (Sigma) and ionomycin
(Sigma) with the addition of GolgiStop (BD Bioscience). Intracel-
lular staining was performed using an intracellular staining kit
(eBioscience) according to the manufacturer’s protocol. To examine
the expression of phosphorylated STAT (p-STAT)3 and p-STAT5,
cultured cells were stimulated with IL-6 for 30 min before har-
vesting and were stained with anti-p-STAT3-PE and anti-p-STAT5-
Alexa Fluor 488 (both from BD Bioscience). Appropriate isotype
controls were used for gate setting. Cells were analyzed on
ﬂuorescence-activated cell sorting LSRII Fortessa, and the datawere
analyzed with FlowJo software version 7.6 (Tree star, Ashland, OR,
USA). The experiments were conducted at least three times. The
experiments were performed with individual samples from sepa-
rate experiments and not using different wells from the same
culture plate.
2.5. Quantitation of subset of CD4þT cell by ﬂow cytometry
In the analysis of the subsets of CD4þ T cells, the lymphocyte
population was divided by the forward-scattered light/side-scat-
tered light. From this primary gate, CD4þ T cells are identiﬁed by
their expression of CD4 and their characteristic light scatter prop-
erties. From this CD4þ T cell gating, relative percentages of inter-
ested cell populations (e.g., IFNgþ, IL-4þ, IL-17þ, CD25þFoxp3þ, p-
STAT3þ, p-STAT5þ) were identiﬁed by drawing around the
enlarged cluster and by subtracting isotype control versus side
scatter analysis. The results are expressed as the mean of triplicate
samples  the standard deviation (SD).
2.6. Enzyme-linked immunosorbent assay
Antibodies to IFNg, IL-4, and IL-17 were obtained from R&D
Systems. The concentrations of IFNg, IL-4, and IL-17 in the culture
supernatants were measured by sandwich enzyme-linked immu-
nosorbent assay (ELISA), according to the manufacturer’s instruc-
tion. A standard curve was drawn by plotting the optical density
versus the log of the concentration of IFNg, IL-4, or IL-17.
2.7. Mixed lymphocyte reactions culture in vitro
CD4þ T cells derived from C57BL/6 mice were used as the
responder cells and irradiated non-CD4þ cells derived from BALB/c
or C57BL/6 mice were used as APC for allogeneic or syngeneic stim-
ulator cells, respectively. The cells were resuspended in complete
media containing RPMI 1640 supplemented with 5% fetal bovine
serum and 1% antibiotics. Aliquots of 2  105 CD4þ T cells were
cultured with 2  105 irradiated (3,000 cGy) APCs in 96-well plates
J Ginseng Res 2016;40:18e2720containing 200 mL of completemedium andwere incubated for 72 h.
Coculturedcellswerepulsedwith1mCiof (3H)-TdR(thymidine) (NEN
Life Science, Boston, MA, USA) for 18 h before harvesting and were
counted using an automated harvester (PHD Cell Harvester, Cam-
bridge Technology, Cambridge, MA, USA). The results are expressed
as the mean count/min of triplicate samples  the SD.
2.8. Statistical analysis
One-way analysis of variance and the paired-samples t test were
applied using SPSS software (version 19.0; IBM, Armonk, NY, USA).
Data are shown as mean  SD. A p value < 0.05 was taken to be
signiﬁcant.
3. Results
3.1. Determination of the doses of KRGE and CsA
First, we used PI staining to determinate the noncytotoxic
concentrations of KRGE and CsA. CD4þ T cells isolated from sple-
nocytes were exposed to various concentrations of CsA (3 ng/mL,
10 ng/mL, 30 ng/mL, and 60 ng/mL) and KRGE (3 mg/mL, 10 mg/mL,
and 30 mg/mL) when stimulated with anti-CD3 and anti-CD28 an-
tibodies. In this assay, the viable cells are negative for PI uptake and
dead cells are positive for PI uptake (PIþ), as shown in Fig. 1A. The
percentages of dead cells did not differ between control and KRGE-
treated cells at 3e30 ng/mL of CsA (Figs. 1BeD). However, the
percentage of dead cells was signiﬁcantly higher at 60 ng/mL of CsA
compared with the control condition (p < 0.05). Based on these
results, we used the concentrations of 3 mg/mL and 10 mg/mL for
KRGE and 30 mg/mL for CsA for further studies.
3.2. Inﬂuence of KRGE treatment on differentiation of Th1 and Th2
cells during CsA treatment
To determine the impact of CsA and KRGE on the differentiation
of Th1 cells from naïve CD4þ T cells under distinct stimulating
conditions, CD4þ T cells were treated with or without CsA and
KRGE under stimulationwith anti-CD3 and anti-CD28 antibodies to
activate naïve CD4þ T cells. Th1 cells were identiﬁed as the IFNgþ
population of CD4þ cells (CD4þIFNgþ) by ﬂow cytometry (Fig. 2),
and the IFNg concentration in the CD4þ T cell cultured supernatant
was measured by ELISA. The resulting ﬂuorescence proﬁles showed
that CsA reduced the differentiation of Th1 cells (p < 0.05), but that
KRGE did not affect the differentiation of Th1 cells (Fig. 3A, B). The
IFNg concentration in the culture supernatant was also reduced by
CsA (p < 0.001), but not by KRGE (Fig. 3C). We assessed the inﬂu-
ence of KRGE on the differentiation of Th2 cells in the CsA-treated
condition. Differentiated Th2 cells were identiﬁed as IL-4þ cells in
the CD4þ T cell population (CD4þIL-4þ) using ﬂow cytometry
(Figs. 3D, E), and IL-4 concentration was measured by ELISA in the
CD4þ T cell cultured supernatant (Fig. 3F). The resulting ﬂuores-
cence proﬁle showed that neither CsA nor KRGE affected the dif-
ferentiation of Th2 cells or the production of IL-4.
3.3. Inﬂuence of KRGE treatment on differentiation of Th17 cells and
STAT3 expression under CsA treatment
CD4þ T cells were cultured in the Th17-polarizing condition
with or without KRGE and CsA for 72 h. Differentiation of Th17 cells
from naive CD4þ Tcells was assessed by counting the number of IL-
17þ cells using ﬂow cytometry, and IL-17 concentration was
measured by ELISA in the CD4þ T cell cultured supernatant in the
Th17-polarizing condition. Compared with CsA-only treatment,
differentiation of Th17 cells was signiﬁcantly inhibited by CsAtreatment (p< 0.001) and was inhibited further by KRGE (p< 0.05;
Figs. 4A, B). Expression of STAT3 induces activation and differenti-
ation of Th17 cells. Expression of STAT3 was not inﬂuenced by CsA
treatment, whereas KRGE inhibited the expression of STAT3. KRGE
also signiﬁcantly inhibited the expression of STAT3 when cotreated
with CsA (p < 0.05; Figs. 4C, D).
3.4. Inﬂuence of KRGE treatment on the differentiation of Tregs and
STAT5 expression under CsA treatment
Next, we assessed the effect of KRGE on Tregs under CsA
treatment. Foxp3 is a unique transcription factor in CD4þCD25þ
Tregs and has been demonstrated to be critical to the development
of Tregs in the mouse and humans. To determine the effect of
KRGE on Foxp3 protein in CD4þCD25þ T cells, we performed
intracellular staining for Foxp3 protein using anti-Foxp3 mAb with
gating on the CD4þCD25þ population in ﬂow cytometry. As
shown in Figs. 5A and B, most CD4þCD25þ T cells expressed Foxp3
with or without treatment with KRGE and CsA. KRGE-only treat-
ment had no effect on the differentiation of Tregs, whereas CsA
signiﬁcantly inhibited Treg differentiation (p < 0.001). The inhibi-
tion of Treg differentiation by CsA was increased by the addition of
KRGE (p< 0.05; Figs. 5A, B). STAT3 activation induces the activation
and differentiation of Th17 cells. STAT3 regulates the generation of
Th17 cells, whereas activation of STAT5 is required for the expres-
sion of Foxp3 and the differentiation of Tregs. Addition of KRGE
augmented the CsA-induced decrease in the expression of STAT5
(p < 0.05; Figs. 5A, B).
3.5. Inﬂuence of KRGE on the alloreactive T cell response under CsA
treatment
To assess the effects of KRGE on the proliferative capacity of
donor CD4þ T cells in response to alloantigens following trans-
plantation, the alloreactivity of T cells was measured by (3H)-
thymidine incorporation to assess T cell proliferation in the mixed
lymphocyte reaction (MLR). A proliferative response to BALB/c cells
(allogeneic stimulator) was observed in C57BL/6 CD4þ T cells
(responder cells). KRGE had no signiﬁcant effect on this alloreactive
T cell response, whereas CsA inhibited the alloreactivity-induced
proliferation of T cells by inhibiting T cell activation (p < 0.001).
The alloreactivity-induced proliferation of T cells was inhibited
further by KRGE compared with CsA-only treatment (p < 0.05;
Fig. 6A). Cytokine concentrations were measured in the superna-
tant from the coculture of allogeneic stimulator and responder
cells. Both IL-17 production by Th17 cells and IFNg production by
Th1 cells were signiﬁcantly reduced by KRGE in cells cotreatedwith
RGE and CsA compared with CsA-only treatment (p < 0.05). By
contrast, IL-4 production by Th2 cells was not inﬂuenced by KRGE
and CsA (Fig. 6B).To investigate the effects of KRGE on immune
tolerance during the allogeneic T cell response, we assessed the
differentiation of Tregs in response to alloantigens following
transplantation. The resulting ﬂuorescence proﬁle showed that the
increase in the number of Foxp3þCD25þ Tregs in the allogeneic
CD4þ Tcell populationwas reduced by CsA treatment (p< 0.05). By
contrast, KRGE recovered the differentiation of Tregs under stim-
ulation with CsA (p < 0.05; Fig. 6C).
4. Discussion
The present study was undertaken to investigate the effect of
ginseng on the subpopulation of CD4þ T cells and the ability of
these cells to produce cytokines during CsA treatment after stim-
ulation with the TCR or alloantigen. We found that the combined
treatment with KRGE and CsA did not affect the differentiation of
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Fig. 1. Determination of the dose of Korean Red Ginseng extract (KRGE) and cyclosporine A (CsA) for the in vitro test. CD4þ T cells from the spleens of normal C57BL/6 mice were
cultured with antibodies to CD3 and CD28 with CsA and/or KRGE. After 72 h of culture, the cells were stained with propidium iodide (PI) to detect dead cells using ﬂow cytometry.
(A) Representative ﬂow cytometric dot plots showing the side-scattered light (SSC) (cell granularity)/PI gate. The percentage of PIþ cells at the various concentrations of KRGE (B),
CsA (C), and the KRGE þ CsA combination (D). Note that there were no signiﬁcant changes in the number of PIþ cells except at 60 ng/mL of CsA. The data are presented as
means  standard deviation (SD) of three independent experiments. The p value was < 0.05 vs. the other treatment conditions.
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related cytokines. Interestingly, the Th17 cell population and its
transcription factor STAT3 were suppressed signiﬁcantly by KRGE,
and the CsA-induced suppression of Treg differentiation was
markedly recovered by KRGE treatment. Overall, our results pro-
vide evidence that supplementation with ginseng has beneﬁcial
effects against CsA-based immunosuppression.First, we investigated the effect of KRGE on the differentia-
tion of Th1/Th2 cells under CsA treatment, because published
data have indicated that CD4þ Th1 cells are involved in allograft
rejection [18]. Our results showed that CsA inhibited the dif-
ferentiation of CD4þIFNgþ and production of IFNg but did not
alter CD4þIL-4þ cells and production of IL-4. CsA is known to
downregulate IL-2 synthesis, thereby inhibiting Th1, CD8, and
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Fig. 2. Flow cytometric analysis of CD4þT cell subsets. CD4þT cells were isolated using CD4þ T cell isolation kit. Isolated CD4þT cells were stimulated with plate-bound anti-CD3
and soluble anti-CD28 with or without cyclosporine A (CsA) and Korean Red Ginseng extract (KRGE) for 72 h. Anti-interferon gamma (IFNg), anti-interleukin (IL)-4, anti-IL-2, IL-6,
and transforming growth factor-beta (TGF-b) also additionally applied into the isolated CD4þT cells for Th17 cell-polarizing condition. The lymphocyte gating was divided by the
forward-scattered light (FSC) and side-scattered light (SSC). From this primary gate, CD4þT cells were identiﬁed by their expression of CD4 and their characteristic light scatter
properties. Then, relative frequency (%) of interested cell populations [IFNgþ, IL-4þ, IL-17þ, CD25þforkhead box P3 (Foxp3)þ, phosphorylated signal transducer and activator of
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eﬂuorophore; FITC, ﬂuorescein isothiocyanate; PE, phycoerythrin; PerCP, peridinin chlorophyll.
J Ginseng Res 2016;40:18e2722natural killer cells functions and IFNg synthesis. In a study of
clinical transplantation, CD4þ T cell clones isolated from human
kidney allografts during acute rejection produced a high con-
centration of IFNg, but not of IL-4 or IL-5, after stimulation with
phytohemagglutinin, indicating that alloreactive Th1 cells, but
not Th2 cells, are involved in the acute allograft rejection [19].
Similarly, it is known that ginseng extract or its components(e.g., Re or Rg1) suppress IFNg secretion in response to immune
activation, which increases cell viability [20,21]. In this study,
when used together in the nontoxic dose range, KRGE did not
add to the CsA-induced suppression of CD4þIFNgþ cells or to
the reduced IFNg concentration in the cell medium. KRGE
treatment had no effect on the differentiation of CD4þIL-4þ Th2
cells or the secretion of the cytokine IL-4. These ﬁndings suggest
S.B. Heo et al / Immunological effect of ginseng with CsA 23that KRGE treatment does not inﬂuence CsA-based suppression
of Th1 cells.
Next, we investigated the inﬂuence of KRGE on the differentia-
tion of Th17 cells during CsA treatment based on accumulating
evidence that Th17 cells are implicated in allograft rejection. The
Th17 cell is a third subset of effector T cells and is characterized by
the secretion of the proinﬂammatory cytokine IL-17 [7,8]. Th17 cells
act through the secretion of IL-17, which recruits monocytes and
neutrophils, and acts in synergy with other local inﬂammatory
cytokines [22]. In this study, we found that CsA treatment signiﬁ-
cantly inhibited the population of CD4þIL-17þ cells and the IL-17
concentration in the supernatant and that cotreatment with
KRGE further reduced both parameters. Interestingly, p-STAT3, a
main transcription factor in Th17 cells [23,24], was suppressed
signiﬁcantly by KRGE treatment. This ﬁnding conﬁrms that KRGE
can inhibit the differentiation of Th17 cells by inhibiting the tran-
scription of Th17.B
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side-scattered light.There is emerging evidence that allograft function correlates
with the number of Tregs [25]. However, CsA inhibits the genera-
tion of Tregs by inhibiting IL-2 transcription in the thymus and
periphery, and inhibition of calcineurin by CsA restricts the access
of the nuclear factor for Foxp3 [26]. In this study, we testedwhether
KRGE treatment would be effective in inducing Tregs, whose in-
duction is inhibited by CsA-based immunosuppression. We found
that CsA inhibition of the CD4þCD25þFoxp3þ Treg populationwas
recovered by KRGE treatment. p-STAT5, a transcription factor in
Tregs, was also consistently increased by KRGE treatment. This
ﬁnding conﬁrms the effect of ginseng on the generation of Tregs in
immune disorders such as autoimmune encephalomyelitis and
atopic dermatitis [13,27].
Reciprocal regulation of Th17 cells and Tregs has been proposed
recently in a competition model, in which the relative activation of
STAT3 and STAT5 directly dictates the outcome of IL-17 production
in CD4þ T cells [12]. It was demonstrated that STAT3 and STAT5C
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J Ginseng Res 2016;40:18e2724bind to multiple common sites across the locus encoding IL-17 and
that the induction of STAT5 binding by IL-2 is associated with less
binding of STAT3 at these sites. Therefore, therapeutic agents that
inhibit STAT3 may simultaneously upregulate STAT5. Consistent
with these ﬁndings, our results showed that KRGE upregulated
Foxp3 expression in CD4þ T cells even in conditions fostering Th17
cell differentiation. In addition, KRGE increased the number of
Tregs that expressed Foxp3 or STAT5, both of which are critical
transcription factors in Treg cells (Figs. 5 and 6). These ﬁndings
suggest that ginseng treatment is beneﬁcial by reciprocally regu-
lating Th17 and Treg cells during CsA treatment.
In this study to extend our previous ﬁndings, we conﬁrmed the
in vitro alloreactive CD4þ T cell response to KRGE whenS
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scattered light.administered with CsA in an MLR. Wang et al. reported that the
ginsenoside Rd by itself has immunosuppressive effects on skin
allograft rejection in rats [28], but they did not compare this effect
when combined with CsA. In our study, the combined treatment of
KRGE and CsA suppressed alloreactive T cell proliferation (Fig. 6).
This result suggests that KRGE treatment may play an important
role in regulating transplant rejection, although this requires
conﬁrmation by in vivo studies.
Our study has some limitations. First, we determined the
noncytotoxic concentration of CsA and KRGE for lymphocytes in
an in vitro study, as shown in Fig. 1. We did not measure the ab-
sorption rate and pharmacokinetics in an in vitro study, and
further experiments are needed to identify the optimum doses ofL
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Fig. 5. Effect of cotreatment with Korean Red Ginseng extract (KRGE) on the regulatory T cell (Treg) population and signal transducer and activator of transcription 5 (STAT5)
expression during cyclosporine A (CsA) treatment. CD4þ T cells from the spleens of normal C57BL/6 mice were cultured with CsA and/or KRGE in the Th0- or Th17-polarizing
condition. After 72 h of culture, the cells were stained with antibodies to CD4, CD25, and forkhead box P3 (Foxp3) in the Th17-polarizing condition (A and B) and phosphory-
lated STAT5 (p-STAT5) in the Th0 condition (C and D) and analyzed by intracellular ﬂow cytometry. Note that cotreatment with KRGE signiﬁcantly recovered both
CD4þCD25þFoxp3þ cells and p-STAT5 cells compared with the CsA-only condition. The data are presented as means  standard deviation (SD) of three independent experiments.
The p value was < 0.05 vs. the other treatment conditions.
S.B. Heo et al / Immunological effect of ginseng with CsA 25CsA and KRGE in vivo. Second, in this study, we selected two doses
of KRGE (3 mg/mL and 10 mg/mL) based on the results of cellular
toxicity (Fig. 1) and a preliminary test of subset of CD4þT cells.
Much lower or high doses of KRGE did not inﬂuence CsA effects.
We expected dose-dependent effects between 3 mg/mL and 10 mg/
mL of KRGE but could not get statistical signiﬁcance, although
there was tendency to dose-dependency. Third, we applied com-
mercial KRGE rather than speciﬁc ginsenoside compounds. It
would be valuable to study the functions of speciﬁc constituents of
ginseng, because ginseng extracts contain multiple functional
constituents.
In this study, combined treatment of KRGE minimally changed
the population of Th17 cells or Treg cells against CsA-based
immunosuppression. Therefore, we suggest several possibilities.
First, because CsA itself is too strong an immunosuppressant,changes of subset of CD4þT cells are not easy to detect, unlike
immune activation-related diseases (e.g., autoimmune arthritis,
autoimmune encephalomyelitis, and atopic dermatitis). Other-
wise, indeed, the immune-modulatory effect of KRGE may be too
weak to recover during CsA treatment. However, cotreatment with
KRGE did not show side effects on CsA-induced immune sup-
pression at least. Therefore, we suggest that supplements of KRGE
should be taken as subside materials in transplant patients
receiving CsA.
In conclusion, combined treatment with ginseng showed
immunologic safety in CsA-based immunosuppression. It also acts
as an immune regulator through the reciprocal regulation of Th17
and Treg cells. These ﬁndings provide a rationale for the use of
ginseng in transplant and immune-disorder patients receivingwith
CsA.
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Fig. 6. Effect of cotreatment with Korean Red Ginseng extract (KRGE) on the alloreactive T cell response during cyclosporine A (CsA) treatment. CD4þ T cells from the spleens of
normal C57BL/6 mice were cultured with irradiated non-CD4þ T cells from BALB/c mice in a mixed lymphocyte reaction (MLR) during treatment with CsA and/or KRGE for 72 h. (A)
Alloreactive T cell proliferation detected by (3H)-thymidine incorporation. The concentrations of interleukin (IL)-17, interferon gamma (IFNg), and IL-4 in the culture supernatants
(B) and intracellular ﬂow cytometry analysis of cells stained with CD4, CD25, and forkhead box P3 (Foxp3) (C). Note that the cotreatment with KRGE signiﬁcantly increased
regulatory T cells (Tregs) and decreased IL-17 concentration and alloreactive T cell proliferation compared with the CsA-only condition. The data are presented as means  standard
deviation (SD) of three independent experiments. The p value was < 0.05 vs. the other treatment conditions. Allo, allogeneic stimulator; Syn, syngeneic stimulator.
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